Category:
Prophylactic Biological Products
CAS NO:
2326521-71-3
Standard:
In-house Standards,
Adagrasib (CAS 2489568-07-6) is a potent, oral reversible inhibitor of KRAS G12C mutations. Synthesized via advanced organic coupling processes, its molecular formula is C27H27F3N6O3. This small molecule serves as a critical API for targeted oncology therapies.
Strictly store below -20°C under inert atmosphere to maintain stability. Use only in certified laboratory settings with appropriate PPE due to potential cytotoxicity. Not approved for general consumer use.